Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

The new minoxidil hydrogel improves delivery and is safe for treating hair loss.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

Calancardin B may help reduce inflammation in immune cells.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Silver nanoparticles from Laurus nobilis leaves may be a new, safer antiarthritic treatment.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

PDRN from salmon may slow skin aging by improving skin quality and reducing inflammation.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

A woman poisoned with thallium was successfully treated with activated charcoal and Prussian blue.

Nanoemulgel is a better way to deliver drugs through the skin for various conditions.

4-O-Methylhonokiol from Magnolia shows promise for hair growth, cancer, diabetes, and more, but needs better absorption.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Gyungokgo-gamibang extract significantly promotes hair growth and increases hair thickness.

Semaglutide may worsen eating disorders in vulnerable individuals.